Erratum: Inhibition of NF-kB by deoxycholic acid induces miR-21/PDCD4-dependent hepatocellular apoptosis (Scientific Reports (2016) 5 (17528) DOI: 10.1038/srep17528);Inhibition of NF-κ B by deoxycholic acid induces miR-21/PDCD4-dependent hepatocelular apoptosis

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Rodrigues, Pedro M ^a   Afonso, Marta B ^a   Simaõ, André L ^a   Borralho, Pedro M ^a   Rodrigues, Cecília M P ^a   Castro, Rui E ^a  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; DEOXYCHOLIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; MIRN21 MICRORNA, RAT; PDCD4 PROTEIN, RAT;

ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CELL CULTURE; CHEMICALLY INDUCED; DRUG EFFECTS; LIVER CELL; MALE; METABOLISM; NONALCOHOLIC FATTY LIVER; PATHOLOGY; RAT; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELLS, CULTURED; DEOXYCHOLIC ACID; HEPATOCYTES; MALE; MICRORNAS; NF-KAPPA B; NON-ALCOHOLIC FATTY LIVER DISEASE; RATS; SIGNAL TRANSDUCTION;

EID: 84949257807     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep27828     Document Type: Erratum

References (58)

1. Malhi, H., Guicciardi, M. E., Gores, G. J. Hepatocyte death: a clear and present danger. Physiol Rev 90, 1165-1194 (2010).
2. Aranha, M. M. et al. Bile acid levels are increased in the liver of patients with steatohepatitis. Eur J Gastroenterol Hepatol 20, 519-525 (2008).
3. Yoshimoto, S. et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499, 97-101 (2013).
4. Castro, R. E. In Hepatotoxicity: From Genomics to in-vitro and in-vivo, 391-419 (John Willey & Sons, Ltd, 2007).
5. Rodrigues, C. M. P., Fan, G., Ma, X., Kren, B. T., Steer, C. J. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J Clin Invest 101, 2790-2799 (1998).
6. Higuchi, H., Gores, G. J. Bile acid regulation of hepatic physiology: IV. Bile acids and death receptors. Am J Physiol Gastrointest Liver Physiol 284, G734-738 (2003).
7. Higuchi, H., Grambihler, A., Canbay, A., Bronk, S. F., Gores, G. J. Bile acids up-regulate death receptor 5/TRAIL-receptor 2 expression via a c-Jun N-terminal kinase-dependent pathway involving Sp1. J Biol Chem 279, 51-60 (2004).
8. Rodrigues, C. M. P., Fan, G., Wong, P. Y., Kren, B. T., Steer, C. J. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol Med 4, 165-178 (1998).
9. Rodrigues, C. M. P. et al. Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation. Cell Death Differ 6, 842-854 (1999).
10. Qiao, L. et al. Bile acid regulation of C/EBPbeta, CREB, and c-Jun function, via the extracellular signal-regulated kinase and c-Jun NH2-terminal kinase pathways, modulates the apoptotic response of hepatocytes. Mol Cell Biol 23, 3052-3066 (2003).
11. Ferreira, D. M. et al. JNK1/c-Jun-Activation of the p53/miRNA-34a/Sirtuin1 Pathway Contributes to Apoptosis Induced by Deoxycholic Acid in Rat Liver. Mol Cell Biol 34, 1100-1120 (2014).
12. Pereira, D. M., Rodrigues, P. M., Borralho, P. M., Rodrigues, C. M. P. Delivering the promise of miRNA cancer therapeutics. Drug Discov Today 18, 282-289 (2013).
13. Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233 (2009).
14. Szabo, G., Bala, S. MicroRNAs in liver disease. Nat Rev Gastroenterol Hepatol 10, 542-552 (2013).
15. Krichevsky, A. M., Gabriely, G. miR-21: a small multi-faceted RNA. J Cell Mol Med 13, 39-53 (2009).
16. Meng, F. et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133, 647-658 (2007).
17. Wei, J., Feng, L., Li, Z., Xu, G., Fan, X. MicroRNA-21 activates hepatic stellate cells via PTEN/Akt signaling. Biomed Pharmacother 67, 387-392 (2013).
18. Selaru, F. M. et al. MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. Hepatology 49, 1595-1601 (2009).
19. Zhu, Q. et al. miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma. Oncol Rep 27, 1660-1668 (2012).
20. Zhang, Z. et al. The autoregulatory feedback loop of microRNA-21/programmed cell death protein 4/activation protein-1 (MiR-21/PDCD4/AP-1) as a driving force for hepatic fibrosis development. J Biol Chem 288, 37082-37093 (2013).
21. Bitomsky, N., Bohm, M., Klempnauer, K. H. Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosphorylation of c-Jun and recruitment of the coactivator p300 by c-Jun. Oncogene 23, 7484-7493 (2004).
22. Goke, R., Barth, P., Schmidt, A., Samans, B., Lankat-Buttgereit, B. Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1). Am J Physiol Cell Physiol 287, C1541-1546 (2004).
23. Lankat-Buttgereit, B., Goke, R. Programmed cell death protein 4 (pdcd4): a novel target for antineoplastic therapy Biol Cell 95, 515-519 (2003).
24. Biyanee, A., Ohnheiser, J., Singh, P., Klempnauer, K. H. A novel mechanism for the control of translation of specific mRNAs by tumor suppressor protein Pdcd4: inhibition of translation elongation. Oncogene 34, 1384-1392 (2015).
25. Castro, R. E. et al. Identification of microRNAs during rat liver regeneration after partial hepatectomy and modulation by ursodeoxycholic acid. Am J Physiol Gastrointest Liver Physiol 299, G887-897 (2010).
26. Shin, V. Y. et al. NF-kappaB targets miR-16 and miR-21 in gastric cancer: involvement of prostaglandin E receptors. Carcinogenesis 32, 240-245 (2011).
27. Niu, J. et al. DNA damage induces NF-kappaB-dependent microRNA-21 up-regulation and promotes breast cancer cell invasion. J Biol Chem 287, 21783-21795 (2012).
28. Castro, R. E. et al. Differential regulation of cyclin D1 and cell death by bile acids in primary rat hepatocytes. Am J Physiol Gastrointest Liver Physiol 293, G327-334 (2007).
29. Liu, C. et al. MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma. J Hepatol 53, 98-107 (2010).
30. Damania, P. et al. Hepatitis B virus induces cell proliferation via HBx-induced microRNA-21 in hepatocellular carcinoma by targeting programmed cell death protein4 (PDCD4) and phosphatase and tensin homologue (PTEN). PLoS One 9, e91745 (2014).
31. Yan-nan, B. et al. MicroRNA-21 accelerates hepatocyte proliferation in vitro via PI3K/Akt signaling by targeting PTEN. Biochem Biophys Res Commun 443, 802-807 (2014).
32. Asangani, I. A. et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27, 2128-2136 (2008).
33. Hoeflich, K. P. et al. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 406, 86-90 (2000).
34. Schoemaker, M. H. et al. Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation. J Hepatol 39, 153-161 (2003).
35. Hinz, M., Scheidereit, C. The IkappaB kinase complex in NF-kappaB regulation and beyond. EMBO Rep 15, 46-61 (2014).
36. Mercurio, F. et al. IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 278, 860-866 (1997).
37. Ballard, D. W. et al. The 65-kDa subunit of human NF-kappa B functions as a potent transcriptional activator and a target for v-Rel-mediated repression. Proc Natl Acad Sci USA 89, 1875-1879 (1992).
38. Galloway, E. et al. Activation of hepatocytes by extracellular heat shock protein 72. Am J Physiol Cell Physiol 295, C514-520 (2008).
39. Jenkins, G. J. et al. The bile acid deoxycholic acid has a non-linear dose response for DNA damage and possibly NF-kappaB activation in oesophageal cells, with a mechanism of action involving ROS. Mutagenesis 23, 399-405 (2008).
40. Fang, Y. et al. Bile acids induce mitochondrial ROS, which promote activation of receptor tyrosine kinases and signaling pathways in rat hepatocytes. Hepatology 40, 961-971 (2004).
41. Gores, G. J., Miyoshi, H., Botla, R., Aguilar, H. I., Bronk, S. F. Induction of the mitochondrial permeability transition as a mechanism of liver injury during cholestasis: a potential role for mitochondrial proteases. Biochim Biophys Acta 1366, 167-175 (1998).
42. Huo, X. et al. Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-kappaB activation in benign Barrett's epithelial cells. Am J Physiol Gastrointest Liver Physiol 301, G278-286 (2011).
43. Tinel, A. et al. Autoproteolysis of PIDD marks the bifurcation between pro-death caspase-2 and pro-survival NF-kappaB pathway. EMBO J 26, 197-208 (2007).
44. Bethune, J., Artus-Revel, C. G., Filipowicz, W. Kinetic analysis reveals successive steps leading to miRNA-mediated silencing in mammalian cells. EMBO Rep 13, 716-723 (2012).
45. Song, G. et al. MicroRNAs control hepatocyte proliferation during liver regeneration. Hepatology 51, 1735-1743 (2010).
46. Marquez, R. T., Wendlandt, E., Galle, C. S., Keck, K., McCaffrey, A. P. MicroRNA-21 is upregulated during the proliferative phase of liver regeneration, targets Pellino-1, and inhibits NF-kappaB signaling. Am J Physiol Gastrointest Liver Physiol 298, G535-541 (2010).
47. Ng, R., Song, G., Roll, G. R., Frandsen, N. M., Willenbring, H. A microRNA-21 surge facilitates rapid cyclin D1 translation and cell cycle progression in mouse liver regeneration. J Clin Invest 122, 1097-1108 (2012).
48. Lankat-Buttgereit, B., Goke, R. The tumour suppressor Pdcd4: recent advances in the elucidation of function and regulation. Biol Cell 101, 309-317 (2009).
49. Sheedy, F. J. et al. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol 11, 141-147 (2010).
50. Mandrekar, P., Szabo, G. Signalling pathways in alcohol-induced liver inflammation. J Hepatol 50, 1258-1266 (2009).
51. Barrasa, J. I., Olmo, N., Lizarbe, M. A., Turnay, J. Bile acids in the colon, from healthy to cytotoxic molecules. Toxicol In Vitro 27, 964-977 (2013).
52. Bock, F. J., Peintner, L., Tanzer, M., Manzl, C., Villunger, A. P53-induced protein with a death domain (PIDD): master of puppets Oncogene 31, 4733-4739 (2012).
53. Janssens, S., Tinel, A. The PIDDosome, DNA-damage-induced apoptosis and beyond. Cell Death Differ 19, 13-20 (2012).
54. Bock, F. J. et al. Loss of PIDD limits NF-kappaB activation and cytokine production but not cell survival or transformation after DNA damage. Cell Death Differ 20, 546-557 (2013).
55. Ferreira, D. M. et al. Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease. Diabetologia 54, 1788-1798 (2011).
56. Jia, X. et al. A possible role of chenodeoxycholic acid and glycine-conjugated bile acids in fibrotic steatohepatitis in a dietary rat model. Dig Dis Sci 59, 1490-1501 (2014).
57. Castro, R. E. et al. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease. J Hepatol 58, 119-125 (2013).
58. Luedde, T., Schwabe, R. F. NF-kappaB in the liver-linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 8, 108-118 (2011).